2024
Intravascular imaging-guided vs. angiography-guided percutaneous coronary intervention: A systematic review and meta-analysis of randomized controlled trials in high-risk patients and complex coronary anatomies
Teixeira L, Ferreira R, Navalha D, Pasqualotto E, Fae I, Gibicoski T, Chavez M, Talavera A, Athayde G, Chamie D. Intravascular imaging-guided vs. angiography-guided percutaneous coronary intervention: A systematic review and meta-analysis of randomized controlled trials in high-risk patients and complex coronary anatomies. International Journal Of Cardiology 2024, 416: 132510. PMID: 39222885, DOI: 10.1016/j.ijcard.2024.132510.Peer-Reviewed Original ResearchConceptsHigh-risk patientsPercutaneous coronary interventionMeta-analysis of randomized controlled trialsRandomized controlled trialsTarget vessel failureComplex coronary anatomyCoronary anatomyComplex lesionsRisk ratioCardiovascular mortalityStent thrombosisMyocardial infarctionControlled trialsAngiography-guided percutaneous coronary interventionProcedure-related complicationsMeta-analysisRisk of MACEAdverse cardiac eventsConfidence intervalsSystematic reviewIntravascular imagingRandom-effects modelNo significant differenceCardiac eventsPrimary outcomeIntravascular Imaging–Guided Versus Angiography‐Guided Percutaneous Coronary Intervention: A Systematic Review and Meta‐Analysis of Randomized Trials
Sreenivasan J, Reddy R, Jamil Y, Malik A, Chamie D, Howard J, Nanna M, Mintz G, Maehara A, Ali Z, Moses J, Chen S, Chieffo A, Colombo A, Leon M, Lansky A, Ahmad Y. Intravascular Imaging–Guided Versus Angiography‐Guided Percutaneous Coronary Intervention: A Systematic Review and Meta‐Analysis of Randomized Trials. Journal Of The American Heart Association 2024, 13: e031111. PMID: 38214263, PMCID: PMC10926835, DOI: 10.1161/jaha.123.031111.Peer-Reviewed Original ResearchConceptsAdverse cardiac eventsPercutaneous coronary interventionAngiography-guided percutaneous coronary interventionTarget vessel revascularizationTarget-lesion revascularizationCardiac eventsCardiac deathImaging-guided percutaneous coronary interventionWeighted mean follow-up durationMeta-analysisPrimary outcomeMean follow-up durationStent thrombosisMeta-analysis of randomized trialsStudy-level meta-analysisComplex lesion subsetsIntravascular imagingAll-cause deathRandom-effects meta-analysisStandard of careIntention-to-treat principleUpdates of clinical guidelinesMixed-effects meta-regressionComplex percutaneous coronary interventionIntravascular imaging-guided percutaneous coronary intervention
2023
Rationale and design of the INVICTUS Registry: (Multicenter Registry of Invasive and Non-Invasive imaging modalities to compare Coronary Computed Tomography Angiography, Intravascular Ultrasound and Optical Coherence Tomography for the determination of Severity, Volume and Type of coronary atherosclerosiS)
Nakanishi R, Okubo R, Sobue Y, Kaneko U, Sato H, Fujimoto S, Nozaki Y, Kajiya T, Miyoshi T, Ichikawa K, Abe M, Kitagawa T, Ikenaga H, Osawa K, Saji M, Iguchi N, Nakazawa G, Takahashi K, Ijich T, Mikamo H, Kurata A, Moroi M, Iijima R, Malkasian S, Crabtree T, Chamie D, Alexandra L, Min J, Earls J, Matsuo H. Rationale and design of the INVICTUS Registry: (Multicenter Registry of Invasive and Non-Invasive imaging modalities to compare Coronary Computed Tomography Angiography, Intravascular Ultrasound and Optical Coherence Tomography for the determination of Severity, Volume and Type of coronary atherosclerosiS). Journal Of Cardiovascular Computed Tomography 2023, 17: 401-406. PMID: 37679247, DOI: 10.1016/j.jcct.2023.08.011.Peer-Reviewed Original ResearchConceptsCoronary CT angiographyOptical coherence tomographyCoronary artery diseaseCoronary artery dimensionsInvasive imaging modalitiesImaging modalitiesCore laboratoryDiagnostic value of coronary CT angiographyCoronary arteryIntravascular ultrasoundArtery dimensionsCoronary atherosclerosis burdenEvaluating coronary artery diseaseImaging core laboratoryArtificial intelligenceNIRS-IVUSNoninvasive imaging modalityAtherosclerosis phenotypesCT angiographyProspective studyBlinded fashionCoherence tomographyAtherosclerosis burdenArtery diseaseDiagnostic valueThe ability of contemporary cardiologists to judge the ischemic impact of a coronary lesion visually
Foley M, Rajkumar C, Ahmed-Jushuf F, Nour D, Fung C, Seligman H, Pathimagaraj R, Petraco R, Sen S, Nijjer S, Howard J, Ahmad Y, Allahwala U, Bhindi R, Chamie D, Doi S, Kuwata S, Kaihara T, Koga M, Ishibashi Y, Higuma T, Tanabe Y, Nakayama M, Kawase Y, Watanabe A, Funayama N, Horinaka R, Hijikata N, Takahashi T, Matsuo H, Hansen P, Manica A, Weaver J, Alzuhairi K, Yong T, Warisawa T, Francis D, Shun-Shin M, Al-Lamee R. The ability of contemporary cardiologists to judge the ischemic impact of a coronary lesion visually. Cardiovascular Revascularization Medicine 2023, 59: 60-66. PMID: 37612169, DOI: 10.1016/j.carrev.2023.08.003.Peer-Reviewed Original ResearchConceptsInstantaneous wave-free ratioAmount of ischaemiaOptimal medical therapyVessel coronary artery diseaseSingle vessel coronary artery diseaseCoronary artery diseaseSingle vessel coronary diseaseVessel coronary diseaseInvasive pressure measurementsVisual assessmentLandmark trialsBlinded investigatorAngina trialArtery diseaseCoronary diseaseCoronary lesionsInvasive counterpartsInterventional cardiologistsVisual estimationCoronary stentingIschemic impactInvasive measurementsStentLesionsRandomized participantsSerial Assessment of Coronary Artery Healing of a Biodegradable Polymer Drug-Eluting Stent at 1, 2, and 3 Months by Optical Coherence Tomography (OCT)-The REPAIR Trial.
Silva G, Meneguz-Moreno R, Costa R, Chamié D, Dangas G, Manica A, Arruda J, Sousa A, Feres F, Costa J. Serial Assessment of Coronary Artery Healing of a Biodegradable Polymer Drug-Eluting Stent at 1, 2, and 3 Months by Optical Coherence Tomography (OCT)-The REPAIR Trial. Journal Of Invasive Cardiology 2023, 35: e225-e233. PMID: 36920890, DOI: 10.25270/jic/22.00349.Peer-Reviewed Original ResearchConceptsOptical coherence tomographyDrug-eluting stentsCoherence tomographyStrut coverageSerial optical coherence tomographyEarly strut coverageImaging follow-upSingle-arm studyAcute coronary syndromeLocal drug toxicityPercutaneous coronary interventionType 2 diabetesFirst-generation drug-eluting stentsOpen-labelOCT assessmentBiodegradable polymer drug-eluting stentsDrug toxicityCoronary syndromeFollow-upMean agePolymer drug-eluting stentsCoronary interventionStentHealing patternPatients
2021
Stent type identification with optical coherence tomography: novelty in search of clinical application.
Chamié D, Petraco R. Stent type identification with optical coherence tomography: novelty in search of clinical application. EuroIntervention 2021, 17: e103-e104. PMID: 34110287, PMCID: PMC9707455, DOI: 10.4244/eijv17i2a19.Peer-Reviewed Original ResearchOptical Coherence Tomography Versus Intravascular Ultrasound and Angiography to Guide Percutaneous Coronary Interventions
Chamié D, Costa J, Damiani L, Siqueira D, Braga S, Costa R, Seligman H, Brito F, Barreto G, Staico R, Feres F, Petraco R, Abizaid A. Optical Coherence Tomography Versus Intravascular Ultrasound and Angiography to Guide Percutaneous Coronary Interventions. Circulation Cardiovascular Interventions 2021, 14: e009452. PMID: 33685212, DOI: 10.1161/circinterventions.120.009452.Peer-Reviewed Original ResearchComparative clinical performance of two types of drug-eluting stents with abluminal biodegradable polymer coating: Five-year results of the DESTINY randomized trial
Prado G, Abizaid A, Meireles G, Sarmento-Leite R, Prudente M, Cantarelli M, Dourado A, Jr J, Perin M, Costantini C, Costa R, Costa J, Chamie D, Campos C, Ribeiro E, Lemos P. Comparative clinical performance of two types of drug-eluting stents with abluminal biodegradable polymer coating: Five-year results of the DESTINY randomized trial. Revista Portuguesa De Cardiologia 2021, 40: 71-76. PMID: 33402278, DOI: 10.1016/j.repc.2020.05.017.Peer-Reviewed Original ResearchMeSH KeywordsAbsorbable ImplantsCoronary Artery DiseaseDrug-Eluting StentsHumansPolymersProsthesis DesignTreatment OutcomeConceptsSirolimus-eluting stentsPrimary endpointClinical performanceDrug-eluting stentsFollow-upStent thrombosisDESTINY trialLong-term follow-upYears of follow-upAdverse cardiac eventsFive-year ratesOptical coherence tomographyTarget lesion revascularizationBiolimus-eluting stentFive-year resultsIntravascular ultrasound assessmentBiodegradable polymer drug-eluting stentsCardiac eventsRandomized studyUltrasound assessmentCardiac deathCoherence tomographyLesion revascularizationPolymer drug-eluting stentsRandomized trials
2020
Twelve-month clinical and imaging outcomes of the uncaging coronary DynamX bioadaptor system.
Verheye S, Vrolix M, Montorfano M, Zivelonghi C, Giannini F, Bedogni F, Dubois C, De Bruyne B, Costa R, Chamié D, de Ribamar Costa J, Kereiakes D, Abizaid A, Colombo A. Twelve-month clinical and imaging outcomes of the uncaging coronary DynamX bioadaptor system. EuroIntervention 2020, 16: e974-e981. PMID: 32894231, DOI: 10.4244/eij-d-20-00763.Peer-Reviewed Original ResearchMeSH KeywordsCoronary AngiographyCoronary Artery DiseaseDrug-Eluting StentsHumansPercutaneous Coronary InterventionSirolimusTomography, Optical CoherenceTreatment OutcomeConceptsLong-term follow-upOptical coherence tomographyAcute lumen gainSecond-generation drug-eluting stentsTarget lesion failureLumen areaDrug-eluting stentsProcedural successMulticentre studyCardiac deathCoherence tomographyFollow-upImaging outcomesRandomised trialsLesion failureIn-segmentPositive remodelingMean vessel areaLumen gainDevice thrombosisIncrease of vesselsTwelve-monthsIntravascular ultrasoundPatientsVessel areaHealing and early stent coverage after ultrathin strut biodegradable polymer‐coated sirolimus‐eluting stent implantation: SiBi optical coherence tomography study
Abhyankar A, Abizaid A, Chamié D, Patel G. Healing and early stent coverage after ultrathin strut biodegradable polymer‐coated sirolimus‐eluting stent implantation: SiBi optical coherence tomography study. Catheterization And Cardiovascular Interventions 2020, 98: 1335-1342. PMID: 33247618, DOI: 10.1002/ccd.29371.Peer-Reviewed Original ResearchConceptsOptical coherence tomographyOCT analysisNeointimal hyperplasiaStent implantationOptical coherence tomography studiesOCT imagesBlinded to patientShort dual antiplatelet therapyIndependent core laboratoryDual antiplatelet therapySirolimus-eluting stent implantationInvestigator-initiated studyPercentage of strutsOCT examinationConsecutive patientsSingle-centerCoherence tomographyMalapposed strutsCore laboratorySES implantationStent lengthPatientsStent coverageTissue coverageStrut tissue coverage
2019
Five-year safety and performance data of a novel third-generation novolimus-eluting bioresorbable scaffold in single de novo lesions.
Verheye S, Costa R, Schofer J, Ormiston J, Maeng M, Dudek D, Skurk C, Botelho R, Costa J, Chamié D, Abizaid A, Boersma E, Abizaid A. Five-year safety and performance data of a novel third-generation novolimus-eluting bioresorbable scaffold in single de novo lesions. EuroIntervention 2019, 15: 685-687. PMID: 30530403, DOI: 10.4244/eij-d-18-00292.Peer-Reviewed Original ResearchDiagnostic Accuracy of 320-Row Computed Tomography for Characterizing Coronary Atherosclerotic Plaques: Comparison with Intravascular Optical Coherence Tomography
Ybarra L, Szarf G, Ishikawa W, Chamié D, Caixeta A, Puri R, Perin M. Diagnostic Accuracy of 320-Row Computed Tomography for Characterizing Coronary Atherosclerotic Plaques: Comparison with Intravascular Optical Coherence Tomography. Cardiovascular Revascularization Medicine 2019, 21: 640-646. PMID: 31501019, DOI: 10.1016/j.carrev.2019.08.010.Peer-Reviewed Original ResearchMeSH KeywordsAgedCholesterolComputed Tomography AngiographyCoronary AngiographyCoronary Artery DiseaseCoronary VesselsCrystallizationFemaleFibrosisHumansMacrophagesMaleMiddle AgedMultidetector Computed TomographyNeovascularization, PathologicPlaque, AtheroscleroticPredictive Value of TestsPrognosisRegistriesReproducibility of ResultsRetrospective StudiesTomography, Optical CoherenceVascular CalcificationConceptsOptical coherence tomographyVulnerable plaque characteristicsLow-attenuation plaqueNapkin-ring signPresence of macrophagesCoherence tomographyPlaque characteristicsNon-invasive evaluationCoronary atherosclerotic plaquesComputed tomographyDiagnostic accuracySpotty calcificationCoronary atheromaPositive remodelingCholesterol crystalsMinimal lumen areaAtherosclerotic plaquesNoncalcified plaqueAttenuation plaqueCoronary segmentsTomographyNeovascularizationPlaque typeFibroatheromaPlaque
2018
Imaging-guided pre-dilatation, stenting, post-dilatation: a protocolized approach highlighting the importance of intravascular imaging for implantation of bioresorbable scaffolds
Ali Z, Galougahi K, Shlofmitz R, Maehara A, Mintz G, Abizaid A, Chamié D, Hill J, Serruys P, Onuma Y, Stone G. Imaging-guided pre-dilatation, stenting, post-dilatation: a protocolized approach highlighting the importance of intravascular imaging for implantation of bioresorbable scaffolds. Expert Review Of Cardiovascular Therapy 2018, 16: 431-440. PMID: 29732926, DOI: 10.1080/14779072.2018.1473034.Peer-Reviewed Original ResearchSerial intravascular ultrasound evaluation of the DESolve™ novolimus‐eluting bioresorbable coronary scaffold system
Barreira G, Costa J, Costa R, Staico R, Chamie D, Slhessarenko J, Tanajura L, Abizaid A, Sousa A, Abizaid A. Serial intravascular ultrasound evaluation of the DESolve™ novolimus‐eluting bioresorbable coronary scaffold system. Catheterization And Cardiovascular Interventions 2018, 92: e368-e374. PMID: 29521477, DOI: 10.1002/ccd.27591.Peer-Reviewed Original ResearchMeSH KeywordsAbsorbable ImplantsAgedCardiovascular AgentsCoated Materials, BiocompatibleCoronary AngiographyCoronary Artery DiseaseCoronary VesselsFemaleHumansMacrolidesMaleMiddle AgedPercutaneous Coronary InterventionPredictive Value of TestsProspective StudiesTime FactorsTreatment OutcomeUltrasonography, InterventionalConceptsBioresorbable coronary scaffoldsSafety of coronary angioplastySuppression of neointimal proliferationAdverse cardiac eventsTime pointsLate lumen lossNon-randomized studiesPercutaneous coronary interventionDevice dimensionsIntravascular ultrasound evaluationScaffold systemConsecutive patientsCoronary scaffoldsPrimary endpointSingle-centerCardiac eventsAngiographic successUltrasound evaluationFollow-upLumen lossCoronary interventionSerial evaluationNeointimal proliferationScaffold areaCoronary angioplastySuboptimal Bifurcation Stenting A Case When the Check Comes Late
Zukowski C, Maia F, Oliveira M, Mattos L, Pontes A, Costa R, Chamié D. Suboptimal Bifurcation Stenting A Case When the Check Comes Late. JACC Cardiovascular Interventions 2018, 11: e37-e40. PMID: 29454725, DOI: 10.1016/j.jcin.2017.11.029.Peer-Reviewed Original Research
2017
Serial Assessment of Strut Coverage of Biodegradable Polymer Drug-Eluting Stent at 1, 2, and 3 Months After Stent Implantation by Optical Frequency Domain Imaging
Chevalier B, Smits P, Carrié D, Mehilli J, Van Boven A, Regar E, Sawaya F, Chamié D, Kraaijeveld A, Hovasse T, Vlachojannis G. Serial Assessment of Strut Coverage of Biodegradable Polymer Drug-Eluting Stent at 1, 2, and 3 Months After Stent Implantation by Optical Frequency Domain Imaging. Circulation Cardiovascular Interventions 2017, 10: e004801. PMID: 29246909, DOI: 10.1161/circinterventions.116.004801.Peer-Reviewed Original ResearchMeSH KeywordsAbsorbable ImplantsAgedCardiovascular AgentsCoronary Artery DiseaseCoronary VesselsDrug-Eluting StentsEuropeFemaleHumansHyperplasiaMaleMiddle AgedNeointimaPercutaneous Coronary InterventionPolyestersPredictive Value of TestsProspective StudiesProsthesis DesignRisk FactorsSirolimusTime FactorsTomography, Optical CoherenceTreatment OutcomeWound HealingConceptsDrug-eluting stentsStrut coverageOverlapped stentsAge of patientsNeointimal hyperplasia thicknessAcute coronary syndromeOptical frequency domain imagingFrequency domain imagingSingle-armBiodegradable polymer drug-eluting stentsMulticenter studyStaging procedureCoronary syndromeMultivessel diseasePolymer drug-eluting stentsStent implantationDrug-eluting technologiesStentPatientsDomain imagingLesionsMonthsImplantationBaselineStrutsThe Effect of Strut Protrusion on Shear Stress Distribution Hemodynamic Insights From a Prospective Clinical Trial
Tenekecioglu E, Torii R, Sotomi Y, Collet C, Dijkstra J, Miyazaki Y, Crake T, Su S, Costa R, Chámie D, Liew H, Santoso T, Onuma Y, Abizaid A, Bourantas C, Serruys P. The Effect of Strut Protrusion on Shear Stress Distribution Hemodynamic Insights From a Prospective Clinical Trial. JACC Cardiovascular Interventions 2017, 10: 1803-1805. PMID: 28882287, DOI: 10.1016/j.jcin.2017.06.020.Peer-Reviewed Original ResearchFirst-in-Human Evaluation of a Novel Polymer-Free Drug-Filled Stent Angiographic, IVUS, OCT, and Clinical Outcomes From the RevElution Study
Worthley S, Abizaid A, Kirtane A, Simon D, Windecker S, Brar S, Meredith I, Shetty S, Sinhal A, Almonacid A, Chamié D, Maehara A, Stone G, Investigators R, Worthley S, Shetty S, Sinhal A, Meredith I, Abizaid A, Jepson N, Bhindi R, Lim S, Stewart P, Barlis P, Walters D, Muller D, Cox S, Bhagwandeen R. First-in-Human Evaluation of a Novel Polymer-Free Drug-Filled Stent Angiographic, IVUS, OCT, and Clinical Outcomes From the RevElution Study. JACC Cardiovascular Interventions 2017, 10: 147-156. PMID: 28104208, DOI: 10.1016/j.jcin.2016.10.020.Peer-Reviewed Original ResearchMeSH KeywordsAustraliaChromium AlloysCoronary AngiographyCoronary Artery DiseaseCoronary RestenosisCoronary ThrombosisCoronary VesselsDrug Therapy, CombinationDrug-Eluting StentsFemaleHumansLatin AmericaMaleMiddle AgedMyocardial InfarctionPercutaneous Coronary InterventionPlatelet Aggregation InhibitorsPredictive Value of TestsProsthesis DesignRisk FactorsSingaporeSirolimusTantalumTime FactorsTomography, Optical CoherenceTreatment OutcomeUltrasonography, InterventionalConceptsLate lumen lossIn-stent late lumen lossDrug-filled stentOptical coherence tomographyLumen lossClinical outcomesCoherence tomographyStrut coverageFirst-in-human evaluationEarly strut coverageDe novo coronary lesionsTarget lesion failure rateAngiographic in-stent late lumen lossBinary angiographic restenosis rateFirst-in-humanTreatment of patientsAngiographic restenosis rateCoronary artery diseaseStent strut coverageResolute zotarolimus-eluting stentZotarolimus-eluting stentPrimary endpointDrug-eluting stentsAntiplatelet therapyLaser-drilled holes
2016
Role of invasive imaging in acute and long‐term assessment of bioresorbable scaffold technology
Chamié D, Garcia‐Garcia H, Costa R, Onuma Y, Abizaid A, Serruys P. Role of invasive imaging in acute and long‐term assessment of bioresorbable scaffold technology. Catheterization And Cardiovascular Interventions 2016, 88: 38-53. PMID: 27797463, DOI: 10.1002/ccd.26815.Peer-Reviewed Original ResearchConceptsBioresorbable scaffold technologyPermanent metallic implantsDrug-eluting capabilityMechanical propertiesComplete bioresorptionScaffold technologyMetal platformMetallic implantsBioresorptionTreatment of coronary artery stenosisIntravascular imaging modalitiesTemporary vesselIntravascular imagingDevicesBRS implantationScaffolding supportVascular healingPost-implantationIntravascular imaging comparison of two metallic limus-eluting stents abluminally coated with biodegradable polymers: IVUS and OCT results of the DESTINY trial
Costa J, Chamié D, Abizaid A, Ribeiro E, Meireles G, Prudente M, Campos C, Castro J, Costa R, Lemos P. Intravascular imaging comparison of two metallic limus-eluting stents abluminally coated with biodegradable polymers: IVUS and OCT results of the DESTINY trial. The International Journal Of Cardiovascular Imaging 2016, 33: 161-168. PMID: 27714601, DOI: 10.1007/s10554-016-0992-z.Peer-Reviewed Original ResearchMeSH KeywordsAbsorbable ImplantsCardiovascular AgentsCoronary Artery DiseaseCoronary VesselsDrug-Eluting StentsHumansMetalsNeointimaPercutaneous Coronary InterventionPolymersPredictive Value of TestsProsthesis DesignSirolimusTime FactorsTomography, Optical CoherenceTreatment OutcomeUltrasonography, Interventional